Blog
RSS FeedPosted by Michael Wonder on 03 Jul 2025
Release of provisional recommendations for expert advisory committees
1 July 2025 - We’re improving our processes, so that people can understand the outcome of expert advice to PHARMAC earlier. ...
Posted by Michael Wonder on 16 Apr 2025
Eli Lilly issues warning for Australia as Trump signals pharma tariffs
15 April 2025 - Eli Lilly says it could pull tens of millions of dollars invested in Australian clinical trials unless ...
Posted by Michael Wonder on 07 Apr 2025
Rule of Two for faster access to medicines
3 April 2025 - Associate Health Minister David Seymour is welcoming Cabinet’s decision to enable medicines to be approved in ...
Posted by Michael Wonder on 01 Dec 2024
Voters clamour for affordable health in election lead-up
30 November 2024 - Threats and delays to affordable medicine access underscore an appetite for higher health spending, with polling placing ...
Posted by Michael Wonder on 11 Nov 2024
Pharmas allege Government communication breakdown in medicine deferral crisis
10 November 2024 - Labor has failed to plan for the consequences of delaying drug subsidies and left hundreds of ...
Posted by Michael Wonder on 07 Nov 2024
Government scrambles after medicines delay outrage
6 November 2024 - Health Minister Mark Butler has directed the PBAC to hold an unprecedented extra meeting, after the ...
Posted by Michael Wonder on 06 Nov 2024
Medicine access debacle deepens with invoices for delayed services
5 November 2024 - Pharmaceutical companies whose medicines have been indefinitely delayed are being charged $200,000 per application despite no services ...
Posted by Michael Wonder on 29 Oct 2024
Breast Cancer Canada 'Progress Report' reveals major gaps in screening and treatment delays across Canada
28 October 2024 - Breast Cancer Canada has released the 2024 Progress Report on Breast Cancer in Canada. ...
Posted by Michael Wonder on 08 Oct 2024
Updated information about PHARMAC's priority lists
8 October 2024 - PHARMAC’s quarterly Pūahoaho Report provides the latest information about applications for medicines, vaccines, and related products that ...
Posted by Michael Wonder on 12 Sep 2024
New medicines could be PBS listed in just four weeks under a proposal the health minister calls 'visionary'
11 September 2024 - Have you ever had to wait for an important and expensive medicine to be subsidised? ...
Posted by Michael Wonder on 11 Sep 2024
HTA review outlines First Nations, pediatric reform and quick, cheap medicine
10 September 2024 - A Government review of Australia’s systems for accessing medicine has said it could slash waiting times ...
Posted by Michael Wonder on 19 Aug 2024
Most expensive treatments remain out of reach without health reform
18 August 2024 - Patients are waiting nearly 600 days to access medicines to which the Therapeutic Goods Administration has ...
Posted by Michael Wonder on 15 Jul 2024
Clinical benefit, reimbursement outcomes, and prices of FDA approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis
11 July 2024 - Project Orbis is a global initiative that aims to streamline regulatory review processes across international regulators in ...
Posted by Michael Wonder on 10 Jul 2024
Updates to the HTA Policy and Methods Review
10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...
Posted by Michael Wonder on 03 Jul 2024
HAS clarifies the framework of the “bet” on early access to medicines
24 June 2024 - Committed to a process of continuous development of its methods, the High Authority of Health is launching ...